Intraluminal deposits: A rare cause of glaucoma drainage implant total obstruction

Eur J Ophthalmol. 2023 Jan;33(1):307-311. doi: 10.1177/11206721221100074. Epub 2022 May 16.

Abstract

Purpose: To report the unforeseen complication of total obstruction of a glaucoma drainage implant (GDI) tube lumen by white deposit material and to present a preliminary report identifying the composition of this material.

Methods: Two subjects with a high IOP due to total obstruction of a GDI tube were reviewed. Both patients had a long history with brinzolamide and timolol maleate eye drops. The GDI tube was swept with a 5-0 polypropylene suture stent in order to open the tube. The intraluminal solid sample was successfully collected from the implant tube in one patient. High-performance liquid chromatography-mass spectrometry (HPLC-MS) was used to determine the origin of the intraluminal sample.

Results: Intraluminal deposits containing components of antiglaucoma drugs e.g., timolol and brinzolamide are a rare cause of total obstruction of GDI tubes.

Conclusions: Our study describes a new cause of total obstruction GDI tubes. The long-term use of timolol maleate and brinzolamide and their presence in the intraluminal solid sample collected from the blocked GDI tube suggest that the glaucoma medication may have a role in the pathogenesis. However, the exact mechanism is unknown and requires further studies.

Keywords: Glaucoma tube shunt; brinzolamide; high-performance liquid chromatography-mass spectrometry; intraluminal deposit material; timolol maleate.

MeSH terms

  • Glaucoma Drainage Implants* / adverse effects
  • Glaucoma* / drug therapy
  • Glaucoma* / etiology
  • Glaucoma* / surgery
  • Humans
  • Intraocular Pressure
  • Timolol / therapeutic use

Substances

  • brinzolamide
  • Timolol